Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
boronate beta-lactamase inhibitor |
| gptkbp:ATCCode |
J01CG14
|
| gptkbp:CASNumber |
1226781-44-7
|
| gptkbp:chemicalFormula |
C10H16BNO7S
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:combines |
gptkb:cefepime
|
| gptkbp:developedBy |
gptkb:Venatorx_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
taniborbactam
|
| gptkbp:indication |
complicated urinary tract infections
carbapenem-resistant Enterobacterales infections |
| gptkbp:mechanismOfAction |
inhibits serine and metallo-beta-lactamases
|
| gptkbp:molecularWeight |
305.12 g/mol
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:synonym |
VNRX-5133
|
| gptkbp:target |
beta-lactamase enzymes
|
| gptkbp:bfsParent |
gptkb:cefepime-taniborbactam
|
| gptkbp:bfsLayer |
8
|